Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Pelvic inflammatory disease associated with Chlamydia trachomatis but not Mycoplasma genitalium in New Zealand

Jeannie Oliphant A B and Sunita Azariah A
+ Author Affiliations
- Author Affiliations

A Auckland Sexual Health Service, Greenlane Clinical Centre, Private Bag 92024, Auckland 1142, New Zealand.

B Corresponding author. Email: jeannieo@adhb.govt.nz

Sexual Health 13(1) 43-48 https://doi.org/10.1071/SH14238
Submitted: 15 December 2014  Accepted: 7 September 2015   Published: 9 November 2015

Abstract

Background: There is a paucity of studies looking at associations between Mycoplasma genitalium and pelvic inflammatory disease (PID). The objectives of this study were to estimate the prevalence of M. genitalium in women attending a sexual health service in New Zealand and secondly to examine for an association of M. genitalium with PID. Methods: Women consecutively attending the service for a sexual health screen (Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis) were recruited to establish a baseline prevalence of M. genitalium. An extra cervical swab was taken for the detection of M. genitalium. Recruitment of additional women with a clinical diagnosis of PID continued until a sufficient sample size was obtained to examine the association of PID with M. genitalium. Women in the baseline sample without PID were used as the control group. Results: The control group included 250 women, with M. genitalium diagnosed in 8.7% (95% CI 5.8–12.9%) and C. trachomatis in 9.9% (95% CI 6.8–14.2%). Ninety-one women were recruited with PID; M. genitalium was diagnosed in 9.9% (95% CI 5.3–17.7%) and C. trachomatis in 27.5% (95% CI 19.4–37.4%). Multivariate analysis using clinically relevant variables showed that a diagnosis of C. trachomatis (OR 2.44, 95% CI 1.24–4.81) but not M. genitalium (OR 0.91, 95% CI 0.38–2.20) was significantly associated with a PID diagnosis. Conclusions: M. genitalium was almost as commonly diagnosed as C. trachomatis in this population. C. trachomatis was the only infection that was significantly associated with PID.


References

[1]  Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicoloured butterfly. Clin Microbiol Rev 2011; 24 498–514.
Mycoplasma genitalium: from chrysalis to multicoloured butterfly.Crossref | GoogleScholarGoogle Scholar | 21734246PubMed |

[2]  Lusk MJ, Konecny P, Naing ZW, et al Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population. Sex Transm Infect 2011; 87 107–9.
Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3M3gs1Cksg%3D%3D&md5=7a12b0b12212d7b821f7962c2a945893CAS | 21071566PubMed |

[3]  Anagrius C, Loré B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005; 81 458–62.
Mycoplasma genitalium: prevalence, clinical significance, and transmission.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2MnksleitA%3D%3D&md5=8585ead6df9b3906a698c5d649c90d29CAS | 16326846PubMed |

[4]  Moi H, Reinton N, Moghaddam A. Mycoplasma genitalium in women with lower genital tract inflammation. Sex Transm Infect 2009; 85 10–4.
Mycoplasma genitalium in women with lower genital tract inflammation.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1M%2Fos12hsg%3D%3D&md5=4f31fca35eefb2096415e07b6a50ba0aCAS | 18842689PubMed |

[5]  Manhart LE, Mostad SB, Baeten JM, et al High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. J Infect Dis 2008; 197 733–6.
High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix.Crossref | GoogleScholarGoogle Scholar | 18266605PubMed |

[6]  Hogdahl M, Kihlstrom E. Leucocyte esterase testing of first-voided urine and urethral and cervical smears to identify Mycoplasma genitalium – infected men and women. Int J STD AIDS 2007; 18 835–8.
Leucocyte esterase testing of first-voided urine and urethral and cervical smears to identify Mycoplasma genitalium – infected men and women.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2sjjs1Kltw%3D%3D&md5=0c8ae3f9c5605c52d9199b69a8498721CAS | 18073017PubMed |

[7]  Taylor-Robinson D, Furr PM, Tully JG, et al Animal models of Mycoplasma genitalium urogenital infection. J Med Sci 1987; 23 561–4.
| 1:STN:280:DyaL1c%2Fjt1ahug%3D%3D&md5=fe52b78bb126e55c65f1b28b94c8f6c0CAS |

[8]  Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; Article ID 30184
Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar |

[9]  Cohen CR, Manhart LE, Bukusi EA, et al Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359 765–6.
Association between Mycoplasma genitalium and acute endometritis.Crossref | GoogleScholarGoogle Scholar | 11888591PubMed |

[10]  Cohen CR, Mugo NR, Astete SG, et al Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect 2005; 81 463–6.
Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2MnksleitQ%3D%3D&md5=ecf5022413242cbb8152a0a6593730b4CAS | 16326847PubMed |

[11]  Taylor-Robinson D, Jensen JS, Svenstrup H, et al Difficulties experienced in defining the microbial cause of pelvic inflammatory disease. Int J STD AIDS 2012; 23 18–24.
Difficulties experienced in defining the microbial cause of pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC383mtVSmsg%3D%3D&md5=a39fbb72a8bf4c623b5b8d12c6fc07ceCAS | 22362682PubMed |

[12]  Oliphant J, Azariah S. Cervicitis: limited clinical utility for the detection of Mycoplasma genitalium in a cross-sectional study of women attending a New Zealand sexual health clinic. Sex Health 2013; 10 263–7.
| 23702105PubMed |

[13]  Lusk MJ, Konecny P. Cervicitis: a review. Curr Opin Infect Dis 2008; 21 49–55.
| 18192786PubMed |

[14]  Ross J, McCarthy GUK. National guideline for the management of pelvic inflammatory disease. Cheshire: British Association for Sexual Health and HIV; 2011. Available online at: http://www.bashh.org [verified 8 December 2014].

[15]  Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29 297–301.
| 1:STN:280:DyaK3M7nvVSmsQ%3D%3D&md5=192933c2ea8f9734c6159640e7d271feCAS | 1706728PubMed |

[16]  Twin J, Taylor N, Garland SM, Hocking JS, Walker J, et al Comparison of two Mycoplasma genitalium real-time PCR detection methodologies. J Clin Microbiol 2011; 49 1140–2.
Comparison of two Mycoplasma genitalium real-time PCR detection methodologies.Crossref | GoogleScholarGoogle Scholar | 21209170PubMed |

[17]  Lawton BA, Rose SB, Bromhead C, Gaitanos LA, MacDonald EJ, Lund KA. High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy. Contraception 2008; 77 294–8.
High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy.Crossref | GoogleScholarGoogle Scholar | 18342654PubMed |

[18]  McGowin CL, Anderson-Smits C. Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog 2011; 7 e1001324
Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXntVajsrs%3D&md5=fab91b006198736d566a92df3023691fCAS | 21637847PubMed |

[19]  Simms I, Eastick K, Mallinson H, et al Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. Sex Transm Infect 2003; 79 154–6.
Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3s7ntFyksg%3D%3D&md5=5275e4ce0a44222c00e9cf7bb60727ceCAS | 12690141PubMed |

[20]  Oakeshott P, Aghaizu A, Hay P, et al Is Mycoplasma genitalium in women the “new Chlamydia?” A community-based prospective cohort study. Clin Infect Dis 2010; 51 1160–6.
Is Mycoplasma genitalium in women the “new Chlamydia?” A community-based prospective cohort study.Crossref | GoogleScholarGoogle Scholar | 20942656PubMed |

[21]  Bjartling C, Osser S, Persson K. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 2010; 117 361–4.
The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXitFGisr8%3D&md5=e19a92df8922017cf088340ab78d79b0CAS | 20015303PubMed |

[22]  Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynaecologic outpatient service. Am J Obstet Gynecol 2012; 206 476.e1–e8.
Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynaecologic outpatient service.Crossref | GoogleScholarGoogle Scholar |

[23]  Doxanakis A, Hayes RD, Chen MY, et al Missing pelvic inflammatory disease? Substantial differences in the rate in which doctors diagnose PID. Sex Transm Infect 2008; 84 518–23.
Missing pelvic inflammatory disease? Substantial differences in the rate in which doctors diagnose PID.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1cjot1yisg%3D%3D&md5=c51b7d697f30cc803c0aaae0d882c5eeCAS | 18723585PubMed |

[24]  Jensen JS, Bradshaw CS, Tabrizi SN, et al Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47 1546–53.
Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXjs1Ohsw%3D%3D&md5=ea71fad9e791f7faba4d20521dfd85a1CAS | 18990060PubMed |

[25]  Anagrius C, Loré B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 2013; 8 e61481
Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXmtlSmu7s%3D&md5=9d183370c2a3257e26e513bd04543dd0CAS | 23593483PubMed |

[26]  Manhart LE, Broad JM, Golden MR. Mycoplasma genitalium: should we treat and how? Clin Infect Dis 2011; 53 S129–42.
Mycoplasma genitalium: should we treat and how?Crossref | GoogleScholarGoogle Scholar | 22080266PubMed |

[27]  Pond M, Nori AV, Witney AA, et al High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis. The need for routine testing and the inadequacy of current treatment options. Clin Infect Dis 2014; 58 631–7.
High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis. The need for routine testing and the inadequacy of current treatment options.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXislersrY%3D&md5=51b61e8d1886a6ae9f46ce524b14d98eCAS | 24280088PubMed |